Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission

Clinical trial NCT05596097 · UNKNOWN

Trial details

NCT number: NCT05596097
Sponsor: LanZhou University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma (DLBCL)

Start date: 2022-10-30
Primary completion: 2024-10-20
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.